title: Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.
abstract: Nicotine modulation of learning may contribute to its abuse liability. The role of hippocampal nicotinic acetylcholine receptors (nAChRs) in the effects of acute, chronic and withdrawal from chronic nicotine on learning was assessed via intrahippocampal drug infusion in mice. Acute dorsal hippocampal nicotine infusion enhanced contextual fear conditioning. Conversely, chronic intrahippocampal infusion of a matched dose had no effect, and withdrawal from chronic infusion impaired learning. Thus, hippocampal functional adaptation, evidenced by learning deficits during abstinence, occurs with the transition from acute to chronic nicotine exposure. To investigate which hippocampal nAChRs mediate these adaptations, C57BL/6, beta2 nAChR subunit knockout (KO), and wildtype (WT) mice treated chronically with systemic nicotine received intrahippocampal dihydro-beta-erythroidine (a high affinity nAChR antagonist). Intrahippocampal dihydro-beta-erythroidine precipitated learning deficits in all but the KO mice. Therefore, the action of nicotine at hippocampal beta2 nAChRs mediates adaptations in hippocampal function that underlie withdrawal deficits in contextual fear conditioning.
authors.affiliation: Department of Psychology/Neuroscience Program, Temple University, 1701 North 13th Street, Philadelphia, PA 19122, USA.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Davis
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Gould
mesh_terms: D000818:Animals; D002540:Cerebral Cortex / Q000502:physiology; D003216:Conditioning, Operant / Q000502:physiology; D004079:Dihydro-beta-Erythroidine / Q000494:pharmacology; D005239:Fear / Q000502:physiology / Q000523:psychology; D006624:Hippocampus / Q000378:metabolism / Q000502:physiology*; D007859:Learning Disabilities / Q000209:etiology* / Q000523:psychology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008845:Microinjections; D009538:Nicotine / Q000008:administration & dosage / Q000494:pharmacology; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000235:genetics / Q000502:physiology*; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000523:psychology; D013788:Thalamus / Q000502:physiology
chemical_list: D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D004079:Dihydro-beta-Erythroidine; D009538:Nicotine